Pocket-based molecule generation with an SE(3)-equivariant language model leads to a potent and selective HPK1 inhibitor with in vivo efficacy
Authors:
- Bin XiBXBin Xi
- Han WangHWHan Wang
- Guanglong SunGSGuanglong Sun
- Bowen ZhangBZBowen Zhang
- Ruihan MaoRMRuihan Mao
- Yuyang GeYGYuyang Ge
- Yang WangYWYang Wang
- Jiangtao ZhangJZJiangtao Zhang
- Yiting PanYPYiting Pan
- Feng ZhouFZFeng Zhou
- Yuji WangYWYuji Wang
- Zhenming LiuZLZhenming Liu
Preprint
Abstract
Deep learning shows promise in structure-based drug discovery, yet challenges persist in generating pharmacologically plausible molecules with valid 3D conformation and decent binding mode in the pocket. We introduce SE3-BiLingoMol, an SE(3)-equivariant Transformer for pocket-based 3D molecule generation, addressing two key limitations of existing language-model approaches. First, it uses Geometric Algebra Transformers for SE(3)-equivariant handling of continuous 3D coordinates. Second, a bidirectional attention mechanism mitigates conformational errors accumulated during autoregressive sampling. These innovations enable SE3-BiLingoMol to generate 2D drug-like, 3D geometrically valid molecules with superior binding modes. Validated on DUD-E dataset containing over 100 targets, the model achieved state-of-the-art performance in de novo design and optimization. We applied SE3-BiLingoMol to design potent and selective inhibitors for HPK1, a promising immunotherapy target. Through an iterative human-AI workflow, integrating AI generation with experimental validations (X-ray crystallography, bioassays), we identified Cmpd. 6. This novel tetracyclic compound demonstrates potent HPK1 inhibition, excellent cellular activity, favorable pharmacokinetics, and robust anti-tumor in vivo efficacy as monotherapy and with PD-1 blockade. Our work establishes a sophisticated generative AI framework for 3D molecule design and demonstrates its application in developing cancer immunotherapy. Highlights: ● SE(3)-Equivariant Language Model for Molecule Generation: We introduce a dual-channel SE(3)-equivariant language model that supports de novo molecule design and optimization, addressing key challenges in prior language model-based 3D molecule generation approaches. ● Discovery of Potent HPK1 Inhibitors: Application of this model led to the discovery of highly selective HPK1 inhibitors with robust in vivo efficacy, resulting in a promising lead compound. ● AI-Guided Rational Drug Development Paradigm: This work establishes a paradigm for AI-guided rational drug development, showcasing AI as a “co-pilot” that inspires drug designers with novel ideas in an “evidence-based context”.Keywords
This publication has 16 references indexed in Scilit:
- Molecule generation for drug design: A graph learning perspectiveFundamental Research, 2026
- How Good are Current Pocket-Based 3D Generative Models?: The Benchmark Set and Evaluation of Protein Pocket-Based 3D Molecular Generative ModelsJournal of Chemical Information and Modeling, 2024
- RETRACTED ARTICLE: Comparing ANI-2x, ANI-1ccx neural networks, force field, and DFT methods for predicting conformational potential energy of organic moleculesScientific Reports, 2024
- Bridging the gap between chemical reaction pretraining and conditional molecule generation with a unified modelNature Machine Intelligence, 2023
- Using macromolecular electron densities to improve the enrichment of active compounds in virtual screeningCommunications Chemistry, 2023
- A pocket-based 3D molecule generative model fueled by experimental electron densityScientific Reports, 2022
- Observing Noncovalent Interactions in Experimental Electron Density for Macromolecular Systems: A Novel Perspective for Protein–Ligand Interaction ResearchJournal of Chemical Information and Modeling, 2022
- De Novo Molecule Design Through the Molecular Generative Model Conditioned by 3D Information of Protein Binding SitesJournal of Chemical Information and Modeling, 2021
- Tapping into the drug discovery potential of AIBiopharma Dealmakers, 2021
- Masked graph modeling for molecule generationNature Communications, 2021